# India Poultry Vaccines Market

> India Poultry Vaccines Market Research Report By Type (Live Attenuated Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines), By Species (Broilers, Layers, Turkeys, Others), By Administration Route (Intramuscular, Subcutaneous, Oral, Inhalation) and By Disease Targeted (Newcastle Disease, Infectious Bursal Disease, Avian Influenza, Marek's Disease) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.59%
- **2024:** $ 102.5 Million
- **2025:** $ 108.85 Million
- **2035:** $ 186.5 Million
- **Key Players:** Zoetis (IN), Merck Animal Health (IN), Boehringer Ingelheim (IN), Hester Biosciences (IN), Indian Immunologicals (IN), Venkateshwara Hatcheries (IN), Ceva Santé Animale (IN), Alltech (IN)

**Report ID:** MRFR/Pharma/48783-HCR · **Pages:** 200 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/india-poultry-vaccines-market-50540

---

## Market Summary

## **India Poultry Vaccines Market Overview**

As per MRFR analysis, the India Poultry Vaccines Market Size was estimated at 270 (USD Million) in 2024. The India Poultry Vaccines Market Industry is expected to grow from 500 (USD Million) in 2025 to 850 (USD Million) by 2035. The India Poultry Vaccines Market CAGR (growth rate) is expected to be around 4.942% during the forecast period (2025 - 2035).

The India Poultry Vaccines Market is witnessing significant developments driven by various market drivers and trends. The rising demand for poultry products, propelled by increasing population and changing dietary habits, is a major force prompting farmers to prioritize poultry health through vaccination.

The Indian government is also focusing on biosecurity measures, aiding the adoption of essential vaccinations to prevent outbreaks of diseases such as avian influenza and Newcastle disease. Moreover, there is a growing awareness among poultry farmers about the importance of preventive healthcare, leading to an increased uptake of vaccines across the country.

Opportunities in the India Poultry Vaccines Market are abundant, particularly in expanding the reach of affordable vaccines to rural farmers. With approximately 70% of India's poultry production occurring in rural areas, effective distribution channels and education on vaccine benefits can enhance overall poultry health and productivity.

Additionally, the development of new and more effective vaccines tailored to regional diseases presents a chance for innovation and growth within the market. Recent trends also indicate a rise in collaborations between private vaccine manufacturers and government bodies to strengthen vaccination programs, ensuring better accessibility and affordability.

The shift towards more sustainable animal husbandry practices is further influencing the market, with a focus on reducing antibiotic usage in favor of vaccination. As India increasingly prioritizes food security and the health of its poultry sector, the focus on vaccine development and distribution is set to intensify, aligning with global best practices in animal health management. These factors collectively underscore the evolving landscape of the poultry vaccines market in India and its potential for future growth.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **India Poultry Vaccines Market Drivers**

### **Increasing Demand for Poultry Products**

The rising population in India, projected to surpass 1.4 billion by 2025, is driving the demand for poultry products, thereby increasing the need for effective poultry vaccines in the India Poultry Vaccines Market Industry. As per the National Agricultural Cooperative Marketing Federation of India, the poultry industry contributes approximately 25 percent to the country's agricultural gross domestic product, indicating significant market potential.

Established organizations like the Indian Poultry Equipment Manufacturers Association are focusing on promoting poultry farming, further fueling the need for vaccination to ensure healthy and productive flocks. With an increase in demand for safe and disease-free poultry products, the India Poultry Vaccines Market is expected to grow in alignment with this trajectory.

### **Government Initiatives and Support**

The Government of India has launched several initiatives to boost the poultry sector, including programs aimed at disease control and prevention. The National Livestock Mission aims to enhance production and productivity in the sector, ensuring farmers benefit from modern veterinary practices, including vaccination. Such initiatives highlight the importance of vaccination in improving livestock health.

The Indian government has allocated significant funds for Research and Development in veterinary sciences as part of its commitment to the poultry vaccine supply chain. The supportive policy environment will also aid the growth of the India Poultry Vaccines Market Industry, which is expected to expand tremendously with increased attention on biosecurity and poultry disease management.

### **Rise in Awareness Regarding Animal Health**

There has been a growing awareness among poultry farmers about the importance of vaccination in maintaining flock health and productivity. According to a survey conducted by the Animal Husbandry department, over 60 percent of poultry farmers now understand the critical role of vaccines in preventing diseases like Newcastle disease and Infectious Bursal Disease.

Additionally, organizations such as the Indian Veterinary Association are actively involved in educating farmers about disease prevention strategies. The increased awareness is driving the demand for poultry vaccines and consequently expanding the India Poultry Vaccines Market Industry as farmers recognize the correlation between vaccinated flocks and higher economic returns.

### **Advancements in Vaccine Technology**

The veterinary vaccination landscape is evolving with advancements in vaccine technology, including the development of recombinant vaccines and live attenuated vaccines that are more effective and safer for poultry. The Indian Council of Agricultural Research is actively promoting research in innovative vaccine formulations.

These advancements are reducing the incidence of poultry diseases and improving overall flock health. With the introduction of improved and efficient vaccines, the commercial poultry sector is likely to experience fewer outbreaks of disease. Consequently, this enhances the return on investment for poultry farmers, thus contributing positively to the growth of the India Poultry Vaccines Market Industry.

## **India Poultry Vaccines Market Segment Insights**

### **Poultry Vaccines Market Type Insights**

The India Poultry Vaccines Market showcases diverse types, each playing a crucial role in maintaining poultry health and productivity. The market emphasizes Live Attenuated Vaccines, which are significant due to their ability to stimulate a strong immune response while providing long-term protection against various diseases. Their effectiveness in combating infections in poultry populations makes them popular among poultry farmers across India.

Inactivated Vaccines also hold a substantial share of the market; these vaccines are essential for their safety profile, offering a reliable option for preventing disease without causing the disease itself, thereby protecting poultry health effectively. Additionally, Subunit Vaccines have gained importance in recent years, especially as they present a focused approach by targeting specific components of pathogens.

This specificity results in a reduced risk of adverse reactions and enhances the safety of vaccinated birds. Furthermore, the incorporation of DNA Vaccines is emerging as a transformative approach, primarily due to their ability to provide a strong immune response and their potential for long-lasting protection. This innovative type of vaccine is particularly relevant in a region like India, where poultry farming is a significant contributor to the livelihoods of many farmers.

The growth of the India Poultry Vaccines Market is driven by the increasing demand for poultry products, necessitating the need for effective vaccination programs to prevent outbreaks of diseases. With the rise in awareness among farmers about disease management and biosecurity measures, there is a growing inclination towards advanced vaccination techniques.

The government initiatives aimed at promoting poultry health and biosecurity, along with investments in Research and Development, further bolster the market. However, challenges such as the need for cold-chain supply management and regional variations in poultry health requirements may impact the accessibility and adoption of certain vaccine types. Overall, the Type segmentation within the India Poultry Vaccines Market continues to evolve, offering opportunities for innovation and expansion in response to the growing needs of the industry.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Poultry Vaccines Market Species Insights**

The Species segment of the India [Poultry Vaccines Market](../../../reports/poultry-vaccines-market-7515) represents a crucial part of the industry, significantly contributing to overall growth and consumer health. Broilers have emerged as a dominant force in this segment due to the high demand for meat production in India, where poultry is a primary protein source for many households.

Layers also play a vital role, given the increasing focus on egg production and the growing awareness among consumers about the nutritional benefits of eggs. Turkeys are gaining traction as consumers become more adventurous with their meat choices, providing opportunities for specialized vaccines to support this segment.

The 'Others' category encompasses various poultry types that, while smaller in volume, cater to niche markets and specialty demands. As the demand for poultry products continues to rise, driven by urbanization and changing dietary habits, the importance of effective vaccination strategies in these segments cannot be overstated.

The India Poultry Vaccines Market revenue is expected to find support in these diverse species categories, reflecting an evolving landscape that prioritizes health, growth performance, and biosecurity in poultry farming practices. Market trends indicate that vaccine innovation and Research and Development will significantly influence the future trajectory of these segments, addressing challenges such as disease outbreaks and antibiotic use.

### **Poultry Vaccines Market Administration Route Insights**

The Administration Route segment of the India Poultry Vaccines Market plays a crucial role in determining the effectiveness and uptake of vaccines. This segment includes various methods such as Intramuscular, Subcutaneous, Oral, and Inhalation, each offering distinct advantages and applications.

Intramuscular vaccination is recognized for its rapid immune response, which is critical in preventing diseases within poultry populations. Subcutaneous methods are often employed for their ease of administration, allowing for efficient mass vaccinations. Oral vaccines are gaining traction due to their user-friendliness and the ability to immunize large groups quickly through feed or water.

Inhalation techniques represent a more novel approach, targeting respiratory diseases prevalent in poultry, particularly in densely populated farming operations. With the Indian government promoting biosecurity measures and vaccination programs to enhance poultry health, the demand for diverse administration routes in vaccines is likely to rise.

This increase not only supports overall poultry production but also contributes to the improvement of the country's food security. Understanding the dynamics of these administration methods is essential, as they represent significant choices for poultry farmers in safeguarding their flocks against common diseases.

### **Poultry Vaccines Market Disease Targeted Insights**

The Disease Targeted segment of the India Poultry Vaccines Market is crucial for ensuring the health and productivity of poultry. Newcastle Disease is one of the foremost concerns, notorious for its rapid spread and high mortality rates, thereby necessitating effective vaccination strategies to protect flocks.

Infectious Bursal Disease also poses significant risks, particularly to young birds, and timely vaccination can prevent large-scale economic losses for farmers. On the other hand, Avian Influenza remains a critical threat not just for poultry but also poses zoonotic risks to humans, making robust vaccination programs vital for public health.

Marek's Disease, while less widespread than the other diseases, still affects immune function, leading to substantial losses in egg production and weight gain in birds. Overall, the importance of these diseases highlights the need for advanced vaccines in India’s poultry industry, as they play a pivotal role in maintaining biosecurity and enhancing market growth. As consumer demand for poultry products increases, the focus on targeted vaccinations is expected to intensify, promoting sustainable farming practices and boosting overall production efficiency in the country.

## **India Poultry Vaccines Market Key Players and Competitive Insights**

The India Poultry Vaccines Market is characterized by a rapidly evolving landscape driven by increasing demand for poultry products and a growing awareness of animal health and welfare. The market is heavily influenced by various factors including government regulations, advancements in veterinary medicine, and the rising incidences of poultry diseases. Companies are constantly innovating and adapting their strategies to enhance production capabilities and expand their portfolios in response to significant competition.

This market is marked by numerous global and regional players who are striving to capture market share through diversified product offerings and strong distribution networks. The competitive dynamics of this sector are further complicated by strategies focused on mergers and acquisitions, collaborations, and partnerships, which are pivotal for scaling operations and enhancing technological capabilities.

Hipra is a notable player in the India Poultry Vaccines Market, recognized for its innovative and research-driven approach to vaccine development. The company has established a strong presence in the Indian poultry industry, focusing on delivering high-quality vaccines that address the unique challenges faced by poultry farmers in the region. Hipra’s strengths lie in its robust research and development capabilities, which have allowed it to introduce cutting-edge vaccine solutions tailored to both viral and bacterial infections in poultry.

The company’s commitment to quality and efficacy, along with a strategic emphasis on customer education and support, has positioned Hipra favorably within a competitive framework. The combination of its comprehensive product portfolio and emphasis on preventive health in poultry contributes significantly to its reputation as a trusted partner among poultry producers across India.

Indian Immunologicals has made a significant mark in the India Poultry Vaccines Market, primarily known for its extensive range of vaccine products specifically designed for poultry health. The company's key offerings include vaccines that address critical diseases, enhancing the immunity and overall health of poultry stocks. Through strategic investments and a focus on research and innovation, Indian Immunologicals has managed to strengthen its market presence, ensuring competitive positioning against both local and international players.

Moreover, the company’s strengths are evident in its ability to adapt to market needs through continuous product development and maintaining stringent quality control measures. Furthermore, Indian Immunologicals has engaged in various mergers and acquisitions that have bolstered its operational capabilities and expanded its product offerings, thereby enhancing its footprint in the Indian poultry vaccines market while reinforcing its commitment to improving animal health standards across the region.

### **Key Companies in the India Poultry Vaccines Market Include**

- **[Hipra](https://www.hipra.com/en/animal-health/knowledge/3-hipra-vaccines-poultry)**
- Indian Immunologicals
- Venkateshwara Hatcheries
- Sysmex
- Ceva Santé Animale
- Piramal Healthcare
- Zoetis
- Vetoquinol
- Hester Biosciences
- Biovet
- Zydus Cadila
- Merck Animal Health
- MSD Animal Health
- Thermo Fisher Scientific
- Boehringer Ingelheim

## **India Poultry Vaccines Market Industry Developments**

The India Poultry Vaccines Market has seen significant developments recently, particularly in the launch of innovative vaccines and expansions by key players. Notably, in September 2023, Hester Biosciences introduced a new vaccine against a prevalent avian disease, improving the health of poultry and meeting rising demand in the region.

Indian Immunologicals has also been active, announcing plans to increase its production capacity for poultry vaccines to cater to the growing market. In terms of mergers and acquisitions, in August 2023, Boehringer Ingelheim announced its acquisition of a local vaccine development firm, strengthening its position in the Indian market.

The market is experiencing healthy growth, driven by rising poultry consumption and increasing awareness of animal health, with estimates projecting a compound annual growth rate of over 10% from 2022 to 2027. Additionally, the ongoing impact of the government's initiatives to enhance biosecurity measures in poultry farming is expected to create new opportunities for vaccine manufacturers. The collective efforts of these companies including Zoetis, Ceva Santé Animale, Merck Animal Health, and others contribute to a dynamic landscape, shaping the future of poultry health in India.

## **India Poultry Vaccines Market Segmentation Insights**

### **Poultry Vaccines Market Type Outlook**

- Live Attenuated Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- DNA Vaccines

### **Poultry Vaccines Market Species Outlook**

- Broilers
- Layers
- Turkeys
- Others

### **Poultry Vaccines Market Administration Route Outlook**

- Intramuscular
- Subcutaneous
- Oral
- Inhalation

### **Poultry Vaccines Market Disease Targeted Outlook**

- Newcastle Disease
- Infectious Bursal Disease
- Avian Influenza
- Marek's Disease

## Market Drivers

### Emerging Disease Threats

The emergence of new poultry diseases poses a significant challenge to the poultry industry in India, thereby driving the demand for vaccines. Recent outbreaks of avian influenza and Newcastle disease have highlighted the vulnerability of poultry flocks to infectious diseases. The India Poultry Vaccines Market is responding to these threats by developing and distributing vaccines that target these specific diseases. The increasing awareness of the potential economic losses associated with disease outbreaks is prompting poultry farmers to prioritize vaccination as a preventive measure. This heightened focus on disease management is likely to propel the growth of the India Poultry Vaccines Market, as farmers seek to protect their flocks and ensure sustainable production.

### Increasing Poultry Production

The demand for poultry products in India is on the rise, driven by a growing population and changing dietary preferences. The India Poultry Vaccines Market is experiencing growth as poultry farmers seek to enhance production efficiency and ensure the health of their flocks. According to recent estimates, the poultry production in India is projected to reach approximately 10 million metric tons by 2026. This surge in production necessitates the use of effective vaccines to prevent diseases that can significantly impact yield. Consequently, the increasing poultry production is a key driver for the India Poultry Vaccines Market, as farmers invest in vaccines to safeguard their investments and meet the escalating demand for poultry products.

### Government Initiatives and Support

The Indian government has implemented various initiatives to bolster the poultry sector, which in turn influences the India Poultry Vaccines Market. Programs aimed at enhancing biosecurity measures and promoting vaccination among poultry farmers are being prioritized. The government has also introduced subsidies for vaccine procurement, making them more accessible to small and medium-sized poultry operations. These initiatives are expected to increase vaccination rates, thereby reducing the incidence of poultry diseases. As a result, the supportive regulatory environment and financial assistance from the government are likely to drive growth in the India Poultry Vaccines Market, fostering a healthier poultry population and improving overall productivity.

### Technological Innovations in Vaccine Development

Advancements in vaccine technology are playing a crucial role in shaping the India Poultry Vaccines Market. Innovations such as recombinant vaccines and vector-based vaccines are being developed to enhance efficacy and reduce the number of doses required. These technological improvements not only increase the effectiveness of vaccines but also streamline the vaccination process for poultry farmers. As a result, the adoption of these advanced vaccines is expected to rise, leading to improved flock health and productivity. The integration of technology in vaccine development is likely to be a driving force in the India Poultry Vaccines Market, as it aligns with the industry's need for efficient and effective disease control measures.

### Growing Consumer Demand for Safe Poultry Products

There is a notable shift in consumer preferences towards safe and healthy poultry products in India. This trend is influencing the India Poultry Vaccines Market, as consumers increasingly demand assurance regarding the health and safety of poultry products. Farmers are responding to this demand by investing in vaccination programs to ensure their flocks are free from diseases. The emphasis on food safety and quality is prompting poultry producers to adopt comprehensive vaccination strategies, thereby driving the growth of the India Poultry Vaccines Market. As consumers continue to prioritize health-conscious choices, the pressure on poultry producers to maintain high standards of animal health will likely sustain the demand for effective vaccines.

## Future Outlook

The India [Poultry Vaccines Market](https://www.marketresearchfuture.com/reports/poultry-vaccines-market-7515) is projected to grow at a 5.59% CAGR from 2025 to 2035, driven by increasing poultry production and rising disease outbreaks.

**New opportunities:**

- Development of customized vaccine formulations for regional poultry diseases. Expansion of digital platforms for vaccine tracking and management. Investment in advanced cold chain logistics for vaccine distribution.

By 2035, the market is expected to be robust, driven by innovation and strategic investments.

## Segment Insights

### By Application: Infectious Bronchitis (Largest) vs. Newcastle Disease (Fastest-Growing)

In the India Poultry Vaccines Market, the application segment showcases a diverse landscape of vaccine types, with Infectious Bronchitis leading the market in share due to its widespread impact on poultry health. Following closely is Newcastle Disease, which is gaining traction as one of the fastest-growing segments, driven by increasing vaccination awareness and the rise of poultry farming practices across regions. Other notable applications include Avian Influenza, Marek's Disease, and Coryza, each contributing to the overall health management of poultry in the country.

Infectious Bronchitis: Dominant vs. Newcastle Disease: Emerging

Infectious Bronchitis remains the dominant force in the India Poultry Vaccines Market due to its severe economic impact on the poultry sector, with producers acknowledging its importance through consistent vaccination practices. On the other hand, Newcastle Disease, recognized for its threats to both poultry health and productivity, is emerging rapidly as farmers become more informed about vaccines' preventive measures. The rising demand for biosecurity and disease management is further establishing Newcastle Disease vaccinations as essential, signaling a transition in market dynamics where both applications will play critical roles in ensuring poultry welfare and production efficiency.

### By Type: Live Attenuated Vaccines (Largest) vs. Recombinant Vaccines (Fastest-Growing)

In the India Poultry Vaccines Market, live attenuated vaccines hold the largest share of the segment, reflecting their widespread acceptance due to proven efficacy and long-lasting immunity in poultry populations. Meanwhile, recombinant vaccines are rapidly expanding, driven by advancements in genetic engineering that enhance their specificity and safety, appealing to a more health-conscious farming community.
Growth trends within this segment indicate a notable shift towards innovative vaccine technologies. As poultry farming evolves with an increased focus on biosecurity and disease management, the demand for inactivated vaccines is also rising. Furthermore, the growing awareness of animal welfare and nutritional benefits is influencing farmers to adopt recombinant and DNA vaccines, leading to a dynamic market landscape.

Live Attenuated Vaccines (Dominant) vs. Inactivated Vaccines (Emerging)

Live attenuated vaccines are recognized as the dominant force within the Indian poultry vaccines market due to their long-standing success in immunizing against various poultry diseases. These vaccines effectively induce strong immune responses, enabling farmers to maintain the health and productivity of their flocks. Conversely, inactivated vaccines are emerging as a pivotal segment driven by their safety profile and effectiveness in disease prevention. These vaccines are increasingly being sought after, particularly in operations focused on organic or antibiotic-free farming practices. As the market continues to evolve, both vaccine types are expected to coexist, catering to the diverse needs of poultry producers in India.

### By Route of Administration: Intramuscular (Largest) vs. Oral (Fastest-Growing)

The route of administration segment in the India Poultry Vaccines Market showcases a diverse landscape, with intramuscular administration holding the largest market share. This method is widely preferred for its efficacy and rapid absorption rate, making it the go-to choice for vaccination in poultry. Oral administration, while holding a smaller share, is rapidly gaining popularity due to its ease of application and logistical advantages, particularly in larger farming operations. The growth trends within this segment are influenced by several factors, including advancements in vaccine technology and the increased awareness of biosafety among poultry farmers. The shift towards oral vaccines is notable, as it often facilitates mass vaccination campaigns, ultimately driving the demand for this method. As farmers seek more efficient solutions, the oral route is positioned to expand significantly over the coming years.

Intramuscular (Dominant) vs. Subcutaneous (Emerging)

In the India Poultry Vaccines Market, the intramuscular route of administration is dominant due to its effectiveness in delivering vaccines directly into muscle tissues, resulting in robust immune responses. It is widely adopted among poultry producers for its reliability and established protocols. In contrast, the subcutaneous route is emerging, offering advantages such as reduced stress on birds and easier administration. This method is garnering attention as it may reduce the burden of handling and restraining the animals during vaccination, addressing animal welfare concerns. While intramuscular methods remain the standard, the subcutaneous approach is becoming more relevant as farmer preferences evolve towards more animal-friendly techniques.

### By Target Species: Broilers (Largest) vs. Layers (Fastest-Growing)

The India Poultry Vaccines Market shows a clear segmentation by target species, with broilers holding the largest share due to their critical role in India's meat production. They are favored for their rapid growth and efficiency in conversion, propelling the demand for specialized vaccines to ensure their health and productivity. Layers, on the other hand, are emerging as the fastest-growing segment, driven by the escalating demand for egg production in urban areas. A surge in poultry farming practices has further accelerated this trend, leading to increased investment in vaccine development for layers. In terms of growth trends, the broiler segment benefits from advancements in veterinary medicine and vaccination techniques that enhance growth rates and overall flock health. Additionally, government initiatives support the poultry sector's development, promoting biosecurity and vaccination protocols. The layers segment, fueled by changing dietary preferences and rising awareness of health benefits, is witnessing an expansion in innovative vaccine solutions tailored to combat specific diseases. As consumer preferences evolve, this segment is on track for considerable growth, highlighting the importance of targeted vaccine strategies to achieve optimal production and safety.

Broilers (Dominant) vs. Layers (Emerging)

Broilers continue to dominate the India Poultry Vaccines Market due to their significant contribution to meat supply and the efficiency of production. With breeding practices aimed at achieving faster growth rates, broilers have a well-defined vaccination schedule to prevent diseases that can hinder growth and productivity. The market for broiler vaccines includes a range of products tailored to address common ailments, thus promoting better health and maximizing yield. Conversely, layers represent an emerging segment driven by the rising demand for eggs, as per capita consumption continues to grow. The focus for vaccines in this segment is primarily on preventing diseases that affect egg production and overall bird health, ensuring high-quality output. The shift towards improved biosecurity measures and innovative vaccination solutions is expected to play a critical role in the growth prospects for layer vaccines in the coming years.

### By Formulation: Liquid (Largest) vs. Lyophilized (Fastest-Growing)

In the India poultry vaccines market, the formulation segment showcases a diverse range of products including liquid, lyophilized, powder, emulsion, and suspension types. Among these, liquid formulations hold the largest market share due to their ease of administration and widespread acceptance among poultry farmers. Meanwhile, lyophilized vaccines are gaining significant traction, especially in rural markets where storage and handling of vaccines are critical factors affecting vaccination rates.

Liquid (Dominant) vs. Lyophilized (Emerging)

Liquid vaccines are the dominant formulation in the Indian poultry vaccines market, known for their user-friendliness and quick action, making them highly preferred for mass vaccination programs. They are easily administered via drinking water or injection, which enhances their appeal for large-scale poultry operations. Conversely, lyophilized vaccines are emerging rapidly, primarily due to advancements in freeze-drying technology that have improved their stability and shelf life. This formulation is particularly advantageous in areas with limited cold chain infrastructure, as it can be stored at ambient temperatures without losing efficacy, making it a strong contender in the growing market.

## Competitive Benchmarking

The Poultry Vaccines Market in India is characterized by a dynamic competitive landscape, driven by increasing demand for poultry products and a growing awareness of animal health. Key players such as Zoetis (IN), Merck Animal Health (IN), and Hester Biosciences (IN) are strategically positioned to leverage innovation and regional expansion to enhance their market presence. Zoetis (IN) focuses on developing advanced vaccine formulations, while Merck Animal Health (IN) emphasizes partnerships with local distributors to optimize supply chains. Hester Biosciences (IN) is actively investing in research and development to introduce novel vaccines, which collectively shapes a competitive environment that is increasingly focused on technological advancements and customer-centric solutions.
The market structure appears moderately fragmented, with several players vying for market share. Key business tactics include localizing manufacturing to reduce costs and enhance supply chain efficiency. This strategy not only mitigates risks associated with global supply chain disruptions but also allows companies to respond swiftly to regional demands. The collective influence of these key players fosters a competitive atmosphere where innovation and operational efficiency are paramount.
In December 2025, Zoetis (IN) announced the launch of a new vaccine targeting avian influenza, which is expected to significantly enhance poultry health and productivity. This strategic move underscores the company's commitment to addressing emerging health challenges in the poultry sector. By introducing this vaccine, Zoetis (IN) aims to solidify its market leadership and respond to the increasing prevalence of avian diseases, thereby reinforcing its competitive edge.
In November 2025, Merck Animal Health (IN) expanded its distribution network through a partnership with local veterinary clinics across India. This initiative is likely to enhance accessibility to their vaccine products, thereby increasing market penetration. The strategic importance of this partnership lies in its potential to improve customer engagement and foster trust within the local farming communities, which is crucial for long-term growth.
In October 2025, Hester Biosciences (IN) secured a collaboration with a leading agricultural university to develop next-generation vaccines. This partnership is indicative of a broader trend towards academia-industry collaboration, which may accelerate innovation in vaccine development. By leveraging academic research, Hester Biosciences (IN) could enhance its product offerings and maintain a competitive advantage in a rapidly evolving market.
As of January 2026, current trends in the Poultry Vaccines Market indicate a shift towards digitalization, sustainability, and the integration of AI technologies. Strategic alliances are increasingly shaping the competitive landscape, allowing companies to pool resources and expertise. The evolution of competitive differentiation appears to be moving away from price-based competition towards a focus on innovation, technology, and supply chain reliability. This transition suggests that companies that prioritize research and development, alongside sustainable practices, are likely to thrive in the future.

## Recent News & Developments

The India Poultry Vaccines Market has seen significant developments recently, particularly in the launch of innovative vaccines and expansions by key players. Notably, in September 2023, Hester Biosciences introduced a new vaccine against a prevalent avian disease, improving the health of poultry and meeting rising demand in the region.

Indian Immunologicals has also been active, announcing plans to increase its production capacity for poultry vaccines to cater to the growing market. In terms of mergers and acquisitions, in August 2023, Boehringer Ingelheim announced its acquisition of a local vaccine development firm, strengthening its position in the Indian market.

The market is experiencing healthy growth, driven by rising poultry consumption and increasing awareness of animal health, with estimates projecting a compound annual growth rate of over 10% from 2022 to 2027. Additionally, the ongoing impact of the government's initiatives to enhance biosecurity measures in poultry farming is expected to create new opportunities for vaccine manufacturers. The collective efforts of these companies including Zoetis, Ceva Santé Animale, Merck Animal Health, and others contribute to a dynamic landscape, shaping the future of poultry health in India.

## Report Scope

| MARKET SIZE 2024 | 102.5(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 108.85(USD Million) |
| MARKET SIZE 2035 | 186.5(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.59% (2024 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Zoetis (IN), Merck Animal Health (IN), Boehringer Ingelheim (IN), Hester Biosciences (IN), Indian Immunologicals (IN), Venkateshwara Hatcheries (IN), Ceva Santé Animale (IN), Alltech (IN) |
| Segments Covered | Application, Type, Route of Administration, Target Species |
| Key Market Opportunities | Increasing demand for innovative vaccines due to rising poultry health awareness in India. |
| Key Market Dynamics | Rising demand for poultry vaccines in India driven by regulatory changes and increasing awareness of animal health. |
| Countries Covered | India |

## Frequently Asked Questions

**Q: What is the current valuation of the India Poultry Vaccines Market?**
A: The India Poultry Vaccines Market was valued at 102.5 USD Million in 2024.

**Q: What is the projected market valuation for the India Poultry Vaccines Market by 2035?**
A: The projected valuation for the India Poultry Vaccines Market is 186.5 USD Million by 2035.

**Q: What is the expected CAGR for the India Poultry Vaccines Market during the forecast period?**
A: The expected CAGR for the India Poultry Vaccines Market from 2025 to 2035 is 5.59%.

**Q: Which companies are the key players in the India Poultry Vaccines Market?**
A: Key players in the market include Zoetis, Merck Animal Health, Boehringer Ingelheim, Hester Biosciences, Indian Immunologicals, Venkateshwara Hatcheries, Ceva Santé Animale, and Alltech.

**Q: What are the main applications of poultry vaccines in the Indian market?**
A: The main applications include Infectious Bronchitis, Newcastle Disease, Avian Influenza, Marek's Disease, and Coryza.

**Q: How much revenue did the Infectious Bronchitis segment generate in 2024?**
A: The Infectious Bronchitis segment generated revenue between 25.0 and 45.0 USD Million in 2024.

**Q: What types of vaccines are prevalent in the India Poultry Vaccines Market?**
A: The prevalent types of vaccines include Live Attenuated Vaccines, Inactivated Vaccines, Recombinant Vaccines, and DNA Vaccines.

**Q: What is the revenue range for Live Attenuated Vaccines in 2024?**
A: Live Attenuated Vaccines generated revenue between 30.0 and 55.0 USD Million in 2024.

**Q: Which target species contribute most to the market revenue?**
A: Broilers, Layers, Breeders, and Turkeys are the primary target species contributing to market revenue.

**Q: What was the revenue range for the Broilers segment in 2024?**
A: The Broilers segment generated revenue between 40.0 and 75.0 USD Million in 2024.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/india-poultry-vaccines-market-50540*